Source: Eur Respir J 2011; 38: 239-243



Rating:

Share or cite this content

Citations should be made in the following way:
Travis W.D., Brambilla E., Van Schil P., Scagliotti G.V., Huber R.M., Sculier J-P., Vansteenkiste J., Nicholson A.G.. Paradigm shifts in lung cancer as defined in the new IASLC/ATS/ERS lung adenocarcinoma classification. Eur Respir J 2011; 38: 239-243

Member's Comments

No comment yet.

Related content which might interest you: Relevance of the novel IASLC/ATS/ERS classification of lung adenocarcinoma in advanced disease Source: Eur Respir J 2014; 43: 1439-1447 Year: 2014 Staging of lung cancer Source: Eur Respir Mon; 2009: 44: 150–168 Year: 2009 Can IASLC/ATS/ERS subtype help predict response to chemotherapy in small biopsies of advanced lung adenocarcinoma? Source: Eur Respir J 2014; 43: 1240-1242 Year: 2014 An algorithm for lung cancer staging Source: School Course 2014- Endoscopic ultrasound in the diagnosing and staging of lung cancer Year: 2014 The new TNM classification of lung cancer in practice Source: Breathe 2011; 7: 348-360 Year: 2011 Does IASLC/ATS/ERS classification of lung adenocarcinoma impacts prognosis? Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 Implications of new lung adenocarcinoma classification for oncologists Source: Annual Congress 2009 - The new ERS/ATS/IASLC classification of lung adenocarcinoma: practice update Year: 2009 Evolution in the diagnostic approach to lung cancer Source: Virtual Congress 2021 – COVID-19 and management of lung cancer Year: 2021 Molecular signatures of non-small cell lung cancer (NSCLC) obtained from gene expression profiling of the benign bronchial mucosa of smokers with and without NSCLC Source: Annual Congress 2013 –Biology and molecular pathology of lung cancer Year: 2013 Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapy Source: Eur Respir J 2012; 39: 1437-1442 Year: 2012 Relationship of T status and metastasis according to new clinical TNM staging in non small cell lung carcinoma Source: International Congress 2015 – Diagnosis and therapy of lung cancer Year: 2015 Prognostic value study of lung cancer molecular markers and value of mitochondrial activity in resected non-small cell lung cancer Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 The role of radiology in lung adenocarcinoma classification Source: Annual Congress 2009 - The new ERS/ATS/IASLC classification of lung adenocarcinoma: practice update Year: 2009 A novel biologic classification of non-small cell lung cancer Source: Annual Congress 2005 - New insights into prognosis in thoracic surgical oncology Year: 2005 Lung cancer or cancer of the lung: a view from the bridge Source: Virtual Congress 2020 – Lung cancer or cancer of the lung Year: 2020 A new TNM classification is better than ISS at predicting survival in stage III unresectable non-small cell lung cancer (NSCLC). A study by the European lung cancer working party (ELCWP) Source: Eur Respir J 2003; 22: Suppl. 45, 163s Year: 2003 Influence of histological subtypes of bronchioloalveolar carcinoma on prognosis and treatment Source: Annual Congress 2006 - Prognostic factors in lung cancer Year: 2006